Basic Information
Basic information for AL138899.1-201-16aa-1
Peptide Name AL138899.1-201-16aa-1
Genome Position chr1:158198569-158198616[-]
Species Human
Peptide Sequence MGFHRVSQDGLDLLTS
Peptide Length 16
Unique No (AC112178.1-202-16aa-1,AC083841.2-201-16aa,AC112178.1-201-16aa-1,AC093515.1-201-16aa,AL080317.2-201-16aa-3,AC020656.2-201-16aa-2,AC003681.1-201-16aa-5,AL356481.2-201-16aa,LINC01876-205-16aa-1,LINC01876-206-16aa,CASC19-226-16aa,CASC19-270-16aa,CASC19-278-16aa,AC022068.1-201-16aa-1,AC112178.1-207-16aa-2,AC093515.1-203-16aa,ERICH6-AS1-204-16aa-1,AC112178.1-203-16aa-2,AC112178.1-204-16aa-1,AC112178.1-208-16aa-1,AC112178.1-205-16aa-1,AC112178.1-206-16aa-1,ERICH6-AS1-205-16aa-1,AC093515.1-202-16aa)
Grand Average of Hydropathicity -0.0625
Relative Molecular Mass 2046.25
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000176320;AL138899.1
Transcript ID/Name ENST00000415019;AL138899.1-201
Transcript Length 1999
Coding Ability 0.3417
DNA Sequence Corresponding to Peptide ATGGGGTTTCACCGTGTTAGCCAGGATGGTCTTGATCTCTTGACCTCG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :